Tango Therapeutics | 8-K: Current report
Tango Therapeutics | 8-K: Current report
Tango Therapeutics | 8-K: Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
Tango Therapeutics | DEF 14A: Definitive information statements
Tango Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Tango Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Tango Therapeutics | 8-K: Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
Tango Therapeutics | 8-K: Current report
Tango Therapeutics | 8-K: Tango Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Highlights
Tango Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Tango Therapeutics | 8-K: Current report
Tango Therapeutics | 8-K: Current report
Tango Therapeutics | 8-K: Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Highlights
Tango Therapeutics | 8-K: Current report
Tango Therapeutics | 8-K: Tango Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
Tango Therapeutics | DEFA14A: Others
Tango Therapeutics | DEF 14A: Definitive proxy statements
Tango Therapeutics | 8-K: Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights
Tango Therapeutics | 8-K: Current report
Tango Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data